The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
The Science of Antibiotic Discovery
Open accessAbstract
We are experiencing an antimicrobial resistance (AMR) crisis, brought on by the drying up of the antibiotic discovery pipeline and the resulting unchecked spread of resistant pathogens. Traditional methods of screening environmental isolates or compound libraries have not produced a new drug in over 30 years. Antibiotic discovery is uniquely difficult due to a highly restrictive penetration barrier and other mechanisms that allow bacteria to survive in the presence of toxic compounds. In this Perspective, we analyze the challenges facing discovery and discuss an emerging new platform for antibiotic discovery. The penetration barrier makes screening conventional synthetic compound libraries largely impractical, and actinomycetes, the main source of natural product compounds, have been overmined. The emerging platform is based on understanding the rules that guide the permeation of molecules into bacteria and on advances in microbiology, which enable us to identify and access attractive groups of secondary metabolite producers. Establishing this platform will enable reliable production of lead compounds to combat AMR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Self-citationUpdated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Self-citationMolecular Mechanisms of Antibacterial Multidrug Resistance
Alekshun, M. N., & Levy, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.03.004 · Cited by 1,647
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Self-citationPlasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,317
Antibiotic tolerance facilitates the evolution of resistance
Levin-Reisman, I., Ronin, I., Gefen, O., Braniss, I., Shoresh, N., & Balaban, N. Q. (2017) · Science · doi:10.1126/science.aaj2191 · Cited by 1,251
Isolating "Uncultivable" Microorganisms in Pure Culture in a Simulated Natural Environment
Kaeberlein, T., Lewis, K., & Epstein, S. S. (2002) · Science · doi:10.1126/science.1070633 · Cited by 1,237
Self-citationSchatz, A., Bugle, E., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-55-14461 · Cited by 1,150
Discovery of microbial natural products by activation of silent biosynthetic gene clusters
Rutledge, P. J., & Challis, G. L. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3496 · Cited by 986
Predictive compound accumulation rules yield a broad-spectrum antibiotic
Richter, M. F., Drown, B. S., Riley, A. P., Garcia, A., Shirai, T., Svec, R. L., & Hergenrother, P. J. (2017) · Nature · doi:10.1038/nature22308 · Cited by 891
Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., & Eliopoulos, G. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2398-2402.2004 · Cited by 836
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
A new antibiotic selectively kills Gram-negative pathogens
Imai, Y., Meyer, K. J., Iinishi, A., Favre-Godal, Q., Green, R., Manuse, S., Caboni, M., Mori, M., Niles, S., Ghiglieri, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1791-1 · Cited by 743
Self-citationUse of Ichip for High-Throughput In Situ Cultivation of “Uncultivable” Microbial Species
Nichols, D., Cahoon, N., Trakhtenberg, E. M., Pham, L., Mehta, A., Belanger, A., Kanigan, T., Lewis, K., & Epstein, S. S. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.01754-09 · Cited by 732
Self-citationPhysicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Activated ClpP kills persisters and eradicates a chronic biofilm infection
Conlon, B. P., Nakayasu, E. S., Fleck, L. E., LaFleur, M. D., Isabella, V. M., Coleman, K., Leonard, S. N., Smith, R. D., Adkins, J. N., & Lewis, K. (2013) · Nature · doi:10.1038/nature12790 · Cited by 672
Self-citationPersister formation in Staphylococcus aureus is associated with ATP depletion
Conlon, B. P., Rowe, S. E., Gandt, A. B., Nuxoll, A. S., Donegan, N. P., Zalis, E. A., Clair, G., Adkins, J. N., Cheung, A. L., & Lewis, K. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.51 · Cited by 671
Self-citationXu, L., Sun, X., & Ma, X. (2017) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-017-0191-3 · Cited by 661
Versatility of Aminoglycosides and Prospects for Their Future
Vakulenko, S. B., & Mobashery, S. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.430-450.2003 · Cited by 643
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Self-citationESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
ATP-Dependent Persister Formation in Escherichia coli
Shan, Y., Brown Gandt, A., Rowe, S. E., Deisinger, J. P., Conlon, B. P., & Lewis, K. (2017) · mBio · doi:10.1128/mbio.02267-16 · Cited by 508
Self-citationDysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Effect of tolerance on the evolution of antibiotic resistance under drug combinations
Liu, J., Gefen, O., Ronin, I., Bar-Meir, M., & Balaban, N. Q. (2020) · Science · doi:10.1126/science.aay3041 · Cited by 485
Phylogenetically Novel Uncultured Microbial Cells Dominate Earth Microbiomes
Lloyd, K. G., Steen, A. D., Ladau, J., Yin, J., & Crosby, L. (2018) · mSystems · doi:10.1128/msystems.00055-18 · Cited by 459
Antibiotic development — economic, regulatory and societal challenges
Årdal, C., Balasegaram, M., Laxminarayan, R., McAdams, D., Outterson, K., Rex, J. H., & Sumpradit, N. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0293-3 · Cited by 458
Siderophores from Neighboring Organisms Promote the Growth of Uncultured Bacteria
D'Onofrio, A., Crawford, J. M., Stewart, E. J., Witt, K., Gavrish, E., Epstein, S., Clardy, J., & Lewis, K. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.02.010 · Cited by 453
Self-citationNovel soil bacteria possess diverse genes for secondary metabolite biosynthesis
Crits-Christoph, A., Diamond, S., Butterfield, C. N., Thomas, B. C., & Banfield, J. F. (2018) · Nature · doi:10.1038/s41586-018-0207-y · Cited by 435
Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains
Müller, A., Wenzel, M., Strahl, H., Grein, F., Saaki, T. N. V., Kohl, B., Siersma, T., Bandow, J. E., Sahl, H.-G., Schneider, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611173113 · Cited by 425
Emr, an Escherichia coli locus for multidrug resistance.
Lomovskaya, O., & Lewis, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8938 · Cited by 424
Self-citationGavrish, E., Sit, C. S., Cao, S., Kandror, O., Spoering, A., Peoples, A., Ling, L., Fetterman, A., Hughes, D., Bissell, A., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.014 · Cited by 423
Self-citationHecker, S. J., Reddy, K. R., Totrov, M., Hirst, G. C., Lomovskaya, O., Griffith, D. C., King, P., Tsivkovski, R., Sun, D., Sabet, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00127 · Cited by 422
A new class of synthetic retinoid antibiotics effective against bacterial persisters
Kim, W., Zhu, W., Hendricks, G. L., Van Tyne, D., Steele, A. D., Keohane, C. E., Fricke, N., Conery, A. L., Shen, S., Pan, W., et al. (2018) · Nature · doi:10.1038/nature26157 · Cited by 411
Targeted isolation and cultivation of uncultivated bacteria by reverse genomics
Cross, K. L., Campbell, J. H., Balachandran, M., Campbell, A. G., Cooper, C. J., Griffen, A., Heaton, M., Joshi, S., Klingeman, D., Leys, E., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0260-6 · Cited by 375
Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions
Raheem, N., & Straus, S. K. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02866 · Cited by 369
Optimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Konovalova, A., Kahne, D. E., & Silhavy, T. J. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093754 · Cited by 314
Liu, B., Trout, R. E. L., Chu, G.-H., McGarry, D., Jackson, R. W., Hamrick, J. C., Daigle, D. M., Cusick, S. M., Pozzi, C., De Luca, F., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01518 · Cited by 312
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
Chimeric peptidomimetic antibiotics against Gram-negative bacteria
Luther, A., Urfer, M., Zahn, M., Müller, M., Wang, S.-Y., Mondal, M., Vitale, A., Hartmann, J.-B., Sharpe, T., Monte, F. L., et al. (2019) · Nature · doi:10.1038/s41586-019-1665-6 · Cited by 311
Nagai, J., & Takano, M. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.159 · Cited by 297
Mourtada, R., Herce, H. D., Yin, D. J., Moroco, J. A., Wales, T. E., Engen, J. R., & Walensky, L. D. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0222-z · Cited by 297
Identification of novel antimicrobials using a live-animal infection model
Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., & Ausubel, F. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604055103 · Cited by 294
Self-citationDavis, B. D., Chen, L. L., & Tai, P. C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6164 · Cited by 293
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Recover the lost art of drug discovery
Lewis, K. (2012) · Nature · doi:10.1038/485439a · Cited by 276
Self-citationPENICILLIN AND CEPHALOSPORIN BIOSYNTHETIC GENES: Structure, Organization, Regulation, and Evolution
Aharonowitz, Y., Cohen, G., & Martin, J. F. (1992) · Annual Review of Microbiology · doi:10.1146/annurev.mi.46.100192.002333 · Cited by 272
Shima, J., Hesketh, A., Okamoto, S., Kawamoto, S., & Ochi, K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.24.7276-7284.1996 · Cited by 243
Single-Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea
Taylor, S. N., Marrazzo, J., Batteiger, B. E., Hook, E. W., Seña, A. C., Long, J., Wierzbicki, M. R., Kwak, H., Johnson, S. M., Lawrence, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1706988 · Cited by 243
HipBA–promoter structures reveal the basis of heritable multidrug tolerance
Schumacher, M. A., Balani, P., Min, J., Chinnam, N. B., Hansen, S., Vulić, M., Lewis, K., & Brennan, R. G. (2015) · Nature · doi:10.1038/nature14662 · Cited by 238
Self-citationNatural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus
Tobias, N. J., Wolff, H., Djahanschiri, B., Grundmann, F., Kronenwerth, M., Shi, Y.-M., Simonyi, S., Grün, P., Shapiro-Ilan, D., Pidot, S. J., et al. (2017) · Nature Microbiology · doi:10.1038/s41564-017-0039-9 · Cited by 194
A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier
Hart, E. M., Mitchell, A. M., Konovalova, A., Grabowicz, M., Sheng, J., Han, X., Rodriguez-Rivera, F. P., Schwaid, A. G., Malinverni, J. C., Balibar, C. J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912345116 · Cited by 189
Limitations of Vancomycin in the Management of Resistant Staphylococcal Infections
Kollef, M. H. (2007) · Clinical Infectious Diseases · doi:10.1086/519470 · Cited by 178
Essence of life: essential genes of minimal genomes
Juhas, M., Eberl, L., & Glass, J. I. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.07.005 · Cited by 177
Monoclonal antibody targeting the β-barrel assembly machine of Escherichia coli is bactericidal
Storek, K. M., Auerbach, M. R., Shi, H., Garcia, N. K., Sun, D., Nickerson, N. N., Vij, R., Lin, Z., Chiang, N., Schneider, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800043115 · Cited by 177
AcrB: a mean, keen, drug efflux machine
Kobylka, J., Kuth, M. S., Müller, R. T., Geertsma, E. R., & Pos, K. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14239 · Cited by 171
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Blizzard, T. A., Chen, H., Kim, S., Wu, J., Bodner, R., Gude, C., Imbriglio, J., Young, K., Park, Y.-W., Ogawa, A., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.101 · Cited by 168
Phillips, J. W., Goetz, M. A., Smith, S. K., Zink, D. L., Polishook, J., Onishi, R., Salowe, S., Wiltsie, J., Allocco, J., Sigmund, J., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.011 · Cited by 168
Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes
Johnson, E. O., LaVerriere, E., Emma Office, Stanley, M., Meyer, E. A., Kawate, T., Gomez, J. E., Audette, R. E., Bandyopadhyay, N., Betancourt, N., et al. (2019) · Nature · doi:10.1038/s41586-019-1315-z · Cited by 158
Bacterial symbionts and natural products
Crawford, J. M., & Clardy, J. (2011) · Chemical Communications · doi:10.1039/c1cc11574j · Cited by 155
High Persister Mutants in Mycobacterium tuberculosis
Torrey, H. L., Keren, I., Via, L. E., Lee, J. S., & Lewis, K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155127 · Cited by 153
Self-citationMarshall, C. G., Broadhead, G., Leskiw, B. K., & Wright, G. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6480 · Cited by 146
Odilorhabdins, Antibacterial Agents that Cause Miscoding by Binding at a New Ribosomal Site
Pantel, L., Florin, T., Dobosz-Bartoszek, M., Racine, E., Sarciaux, M., Serri, M., Houard, J., Campagne, J., de Figueiredo, R. M., Midrier, C., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.001 · Cited by 143
Stochastic Variation in Expression of the Tricarboxylic Acid Cycle Produces Persister Cells
Zalis, E. A., Nuxoll, A. S., Manuse, S., Clair, G., Radlinski, L. C., Conlon, B. P., Adkins, J., & Lewis, K. (2019) · mBio · doi:10.1128/mbio.01930-19 · Cited by 142
Self-citationParker, E. N., Drown, B., Geddes, E. J., Lee, H. Y., Ismail, N., Lau, G. W., & Hergenrother, P. J. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0604-5 · Cited by 132
Mechanism-of-Action Classification of Antibiotics by Global Transcriptome Profiling
O’Rourke, A. E., Beyhan, S., Choi, Y., Morales, P., Chan, A. P.-Y., Espinoza, J. L., Dupont, C. L., Meyer, K. J., Spoering, A. L., Lewis, K., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01207-19 · Cited by 123
Self-citationRamos‐Castaneda, J. A., Ruano‐Raviña, A., Barbosa-Lorenzo, R., Paillier-Gonzalez, J. E., Saldaña-Campos, J. C., Salinas, D. F., & Lemos, E. V. (2018) · Journal of Infection · doi:10.1016/j.jinf.2018.02.007 · Cited by 121
Kaplan, N., Albert, M., Awrey, D. E., Bardouniotis, E., Berman, J., Clarke, T. E., Dorsey, M., Hafkin, B., Ramnauth, J., Romanov, V., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01411-12 · Cited by 120
Quinones are growth factors for the human gut microbiota
Fenn, K., Strandwitz, P., Stewart, E. J., Dimise, E. J., Rubin, S., Gurubacharya, S., Clardy, J., & Lewis, K. (2017) · Microbiome · doi:10.1186/s40168-017-0380-5 · Cited by 108
Self-citationDevelopment of a platform for the discovery and practical synthesis of new tetracycline antibiotics
Liu, F., & Myers, A. G. (2016) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2016.03.011 · Cited by 100
Bergval, I., Schuitema, A. R. J., Klatser, P. R., & Anthony, R. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp237 · Cited by 97
Detection of pan drug-resistant Acinetobacter baumannii in Germany
Göttig, S., Gruber, T. M., Higgins, P. G., Wachsmuth, M., Seifert, H., & Kempf, V. A. J. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku170 · Cited by 96
Rajamuthiah, R., Fuchs, B. B., Jayamani, E., Kim, Y., Larkins‐Ford, J., Conery, A. L., Ausubel, F. M., & Mylonakis, E. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089189 · Cited by 96
Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis
Homma, T., Nuxoll, A. S., Gandt, A. B., Ebner, P., Engels, I., Schneider, T., Götz, F., Lewis, K., & Conlon, B. P. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01050-16 · Cited by 96
Self-citationPoinar, G. O. (1993) · Fundamental & applied nematology · Cited by 88
Refining the Natural Product Repertoire in Entomopathogenic Bacteria
Tobias, N. J., Shi, Y., & Bode, H. B. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.04.007 · Cited by 86
Mimics of Host Defense Proteins; Strategies for Translation to Therapeutic Applications
Scott, R. W., & Tew, G. N. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160713130452 · Cited by 80
Uncovering major genomic features of essential genes in Bacteria and a methanogenic Archaea
Grazziotin, A. L., Vidal, N. M., & Venâncio, T. M. (2015) · FEBS Journal · doi:10.1111/febs.13350 · Cited by 57
Jangra, M., Kaur, M., Tambat, R., Rana, R., Maurya, S. K., Khatri, N., Ghafur, A. K., & Nandanwar, H. S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00338-19 · Cited by 44
Persister Cells and Infectious Disease
(2019) · Springer eBooks · doi:10.1007/978-3-030-25241-0 · Cited by 44
Ureadepsipeptides as ClpP Activators
Griffith, E. C., Zhao, Y., Singh, A. P., Conlon, B. P., Tangallapally, R. P., Shadrick, W. R., Liu, J., Wallace, M. J., Yang, L., Elmore, J. M., et al. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00245 · Cited by 42
Self-citationEfforts toward broadening the spectrum of arylomycin antibiotic activity
Liu, J., Smith, P. A., Steed, D. B., & Romesberg, F. E. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.026 · Cited by 40
Evolutionary ecology of beta‐lactam gene clusters in animals
Suring, W., Meusemann, K., Blanke, A., Mariën, J., Schol, T., Agamennone, V., Faddeeva‐Vakhrusheva, A., Berg, M. P., Brouwer, A., van Straalen, N. M., et al. (2017) · Molecular Ecology · doi:10.1111/mec.14109 · Cited by 29
Pharmacokinetics and Pharmacodynamics of Murepavadin in Neutropenic Mouse Models
Melchers, M. J. B., Teague, J., Warn, P. A., Hansen, J. U., Bernardini, F., Wach, A., Obrecht, D., Dale, G. E., & Mouton, J. W. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01699-18 · Cited by 28
Scangarella-Oman, N. E., Ingraham, K. A., Tiffany, C. A., Tomsho, L., Horn, S. F. V., Mayhew, D. N., Perry, C., Ashton, T. C., Dumont, E. F., Huang, J., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01302-19 · Cited by 20
Cited by
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Phage Therapy for Antibiotic-Resistant Bacterial Infections
Hatfull, G. F., Dedrick, R. M., & Schooley, R. T. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-080219-122208 · Cited by 571
Surface-bound reactive oxygen species generating nanozymes for selective antibacterial action
Gao, F., Shao, T., Yu, Y., Xiong, Y., & Yang, L. (2021) · Nature Communications · doi:10.1038/s41467-021-20965-3 · Cited by 465
Discovery of a structural class of antibiotics with explainable deep learning
Wong, F., Zheng, E. J., Valeri, J. A., Donghia, N. M., Anahtar, M. N., Omori, S., Li, A., Cubillos-Ruiz, A., Krishnan, A., Jin, W., et al. (2024) · Nature · doi:10.1038/s41586-023-06887-8 · Cited by 458
Gaurav, A., Bakht, P., Saini, M., Pandey, S., & Pathania, R. (2023) · Microbiology · doi:10.1099/mic.0.001333 · Cited by 351
Metadata
- Authors
- Lewis, K.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 181
- Issue
- 1
- Pages
- 29-45
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W3011829967
- Cited by
- 797
- References
- 97
- FWCI
- 46.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.